Microcurrent Stimulation to Treat Macular Degeneration
- Conditions
- Retinal DiseasesStargardt's DiseaseRetinitis Pigmentosa
- Registration Number
- NCT01790958
- Lead Sponsor
- Retina Institute of Hawaii
- Brief Summary
Microcurrent stimulation thereapy improves retinal efficiency and may restore and/or improve retinal function.
- Detailed Description
This is an observational study in which data will be collected from a group of patients with retinal diseases such as Dry Macular Degeneration, RetinitisPigmentosa, and Stargardt's Disease, who have opted to receive Microcurrent Stimulation Therapy as an alternative treatment for their retinal condition.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Ability to provide written consent and comply with follow up visits
- Age 40 years or older
- ETDRS best corrected visual acuity better than 5 letters
- History of Dry Age Relted Macular Degeneration; Retinitis Pigmentosa; Stargardt's disease
- No Anti-VEGF treatments for at least 3 months prior to study
- No new antioxidant/vitamin supplementation for at least 3 months prior to study
- History of Non-Compliance with regular medical visits
- Significant media opacities (exclude NS 4+) that may interfere with assessing visual acuity
- Presence of pigment epithelial tears or rips
- Known serious allergies to fluorescein dye
- Presence of retinal neovascularization
- Any treatment with an investigation agent in the past 30 days
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measure visual acuity after receiving microcurrent stimulation treatments. 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Retina Institute of Hawaii
🇺🇸Honolulu, Hawaii, United States
Hawaii Cataract Laser Institute - Kona
🇺🇸Kailua-Kona, Hawaii, United States
Hawaii Cataract Laser Institute - Maui
🇺🇸Kahului, Hawaii, United States
Hawaii Cataract Laser Institute - Hilo
🇺🇸Hilo, Hawaii, United States